Table 3.

Clinical characteristics of NPC patients from GSE102349 dataset in distinct subclasses.

Clinical Stage	Cluster 1 (n = 64)	Cluster 2 (n = 24)
I	5 (7.8%)	0 (0%)
II	1 (1.6%)	1 (4.2%)
III	27 (42.2%)	12 (50.0%)
IV	15 (23.4%)	7 (29.2%)
Unknown	16 (25.0%)	4 (16.7%)
Morphology
differentiated	7 (10.9%)	3 (12.5%)
mixed (round & spindle)	21 (32.8%)	11 (45.8%)
N/A	9 (14.1%)	1 (4.2%)
undifferentiated, round	21 (32.8%)	7 (29.2%)
undifferentiated, spindle	6 (9.4%)	2 (8.3%)
Intratumoral Tils %
<30	24 (37.5%)	15 (62.5%)
≥30	33 (51.6%)	8 (33.3%)
Not evaluated	7 (10.9%)	1 (4.2%)
Stromal Tils %
<50	23 (35.9%)	12 (50.0%)
≥50 & <70	7 (10.9%)	4 (16.7%)
≥70	27 (42.2%)	7 (29.2%)
Not evaluated	7 (10.9%)	1 (4.2%)